Skip to main content
. 2017 Nov 11;8(62):105819–105831. doi: 10.18632/oncotarget.22402

Figure 2. PR of urine metabolomic profiles analyzed using 1H-NMR Spectroscopy.

Figure 2

(A) PCA scatter plot of HC (green dots) and CRC patient (blue squares) urine samples. (B) OPLS-DA scatter plot based on the same samples. (C) Statistical validation of the corresponding OPLS-DA model by permutation analysis (200 times). (D) Scores plots of the OPLS-DA prediction model.